Abstract
The International Liver CongressTM (ILC) (the 53rd Annual International Liver Congress) of the European Association for the Study of the Liver (EASL) was held in April from 11 - 15th, 2018 in Paris, France. Over 10,000 delegates confirmed the persistent interest in the area of liver disease especially in viral hepatitis field. Although, no new HCV drugs are entering the HCV treatment arena, there was a considerable amount of new data from studies in the hepatitis field showing that there is still a lot to learn and discuss. In addition, the newly revised EASL practice guidelines for HCV management were released and the corresponding publication is now downloadable from the EASL website (http://www. journal-of-hepatology.eu/article/S0168-8278(18)31968-8/fulltext). These European Association for the Study of Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
